Skip to content
Screener

CG Oncology CGON Inventories

Inventories at other companies

Pfizer logo
PfizerPFE
$2.46B-11.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.14B+12.9%
Gilead Sciences logo
Gilead SciencesGILD
$2.35B+12.4%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$18.86M+123%
UroGen Pharma logo
UroGen PharmaURGN
$24.59M+245%

Other financials

Income statement

See full
Revenue$1.2M—
Operating income-$86.4M-77.3%
Net income-$79.1M-90.8%
EPS (diluted)-$0.90-66.7%

Balance sheet

See full
Cash & equivalents$19.6M+34.3%
Total debt$8.8M+787%
Total equity$1.0B+53.5%
Total assets$1.1B+54.8%

Cash flow

See full
Operating cash flow-$46.4M-66.0%
CapEx$468.0K+3,243%
Free cash flow-$46.9M-67.6%

Valuation

See full
Market cap$6.66B+265%
Enterprise value$6.65B+267%
P/S1,068.9×-2,245×

Profitability

See full
Operating margin-4,056.2%-1,873pp
Net margin-3,602.7%-1,650pp
FCF margin-2,879.6%-1,307pp

Returns & leverage

See full
Return on equity-26.4%+9.3pp
Debt / equity0×0.0×
Current ratio22.2×+0.1×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336918

FAQ

What is CG Oncology's inventories?
CG Oncology (CGON) reported inventories of $1M in Q2 2026.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Ask your AI about CG Oncology's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude